Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102720347 | 10272034 | 7 | F | 20140622 | 20160904 | 20140702 | 20160913 | EXP | PHHY2014IL080692 | NOVARTIS | 27.96 | YR | F | Y | 0.00000 | 20160913 | CN | IL | IL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102720347 | 10272034 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG, QD | 542 | MG | 22527 | .5 | MG | CAPSULE | QD | ||||
| 102720347 | 10272034 | 2 | SS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG, QD | 542 | MG | 22527 | .5 | MG | CAPSULE | QD | ||||
| 102720347 | 10272034 | 3 | SS | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Unknown | UNK | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102720347 | 10272034 | 1 | Multiple sclerosis |
| 102720347 | 10272034 | 3 | Multiple sclerosis relapse |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102720347 | 10272034 | OT |
| 102720347 | 10272034 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102720347 | 10272034 | Abdominal pain | |
| 102720347 | 10272034 | Central nervous system lesion | |
| 102720347 | 10272034 | Depression | |
| 102720347 | 10272034 | Dizziness | |
| 102720347 | 10272034 | Drug hypersensitivity | |
| 102720347 | 10272034 | Gait disturbance | |
| 102720347 | 10272034 | Headache | |
| 102720347 | 10272034 | Hemiparesis | |
| 102720347 | 10272034 | Hepatic enzyme increased | |
| 102720347 | 10272034 | Hypoaesthesia | |
| 102720347 | 10272034 | Intentional overdose | |
| 102720347 | 10272034 | Lymphocyte percentage decreased | |
| 102720347 | 10272034 | Multiple sclerosis relapse | |
| 102720347 | 10272034 | Nausea | |
| 102720347 | 10272034 | Paraesthesia | |
| 102720347 | 10272034 | Paraesthesia oral | |
| 102720347 | 10272034 | Paralysis | |
| 102720347 | 10272034 | Rash pruritic | |
| 102720347 | 10272034 | Skin lesion | |
| 102720347 | 10272034 | Suicidal ideation | |
| 102720347 | 10272034 | Suicide attempt | |
| 102720347 | 10272034 | Vision blurred | |
| 102720347 | 10272034 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102720347 | 10272034 | 1 | 20130909 | 20160829 | 0 | |
| 102720347 | 10272034 | 2 | 20160904 | 0 |